<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="DKK" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-3-1-285898-34356</iati-identifier>
  <reporting-org ref="XM-DAC-3-1" type="10" xml:lang="EN">
   <narrative xml:lang="EN">Ministry of Foreign Affairs, Denmark</narrative>
  </reporting-org>
  <title xml:lang="EN">
   <narrative xml:lang="EN">CEPI</narrative>
  </title>
  <description type="2" xml:lang="EN">
   <narrative xml:lang="EN">Coalition for Epidemic Preparedness Innovations - CEPI - is not-for-profit and works to ensure a fair access to vaccines, surmountable prices and availability in areas that are most affected by new and emerging diseases &#x2013; in particular low income countries. CEPI works in close partnership with WHO and the World Bank and has become one of the lead actors on vaccine development &#x2013; both in regards to preparedness, but also to response and immediate needs such as the COVID-19 pandemic &#x2013; and has the institutional expertise, networks, and agility to move rapidly.</narrative>
  </description>
  <participating-org crs-channel-code="51000" role="2" type="80" xml:lang="EN">
   <narrative xml:lang="EN">Coalition for Epidemic Preparedness Innovations</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-3-1" role="1" type="10" xml:lang="EN">
   <narrative xml:lang="EN">Ministry of Foreign Affairs, Denmark</narrative>
  </participating-org>
  <other-identifier ref="Ministry of Foreign Affairs, Denmark" type="A1">
   <owner-org>
    <narrative xml:lang="EN">2020 - 11595</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="Ministry of Foreign Affairs, Denmark" type="A2">
   <owner-org>
    <narrative xml:lang="EN">2020000112</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-04-30" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">NA</narrative>
   </organisation>
   <person-name>
    <narrative xml:lang="EN">NA</narrative>
   </person-name>
   <mailing-address>
    <narrative xml:lang="EN">Asiatisk Plads 2, 1448 K&#xF8;benhavn K, Denmark</narrative>
   </mailing-address>
  </contact-info>
  <recipient-region code="998" percentage="100" vocabulary="1"></recipient-region>
  <sector code="121" percentage="100" vocabulary="2" xml:lang="EN">
   <narrative xml:lang="EN">Health, General</narrative>
  </sector>
  <sector code="12182" percentage="100" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Medical research</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="954" percentage="100" vocabulary="4">
    <description>
     <narrative xml:lang="EN">FL &#xA7;06.38.02.12 Partnerships for market-based growth</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <policy-marker code="5" significance="0" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="1" significance="2" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="2" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1" xml:lang="EN"></policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1" xml:lang="EN"></policy-marker>
  <policy-marker code="12" significance="0" vocabulary="1" xml:lang="EN"></policy-marker>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <budget type="1">
   <period-start iso-date="2020-04-01"></period-start>
   <period-end iso-date="2020-06-30"></period-end>
   <value currency="DKK" value-date="2020-04-01">10000000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-04-30"></transaction-date>
   <value currency="DKK" value-date="2020-04-30">10000000</value>
   <flow-type code="10"></flow-type>
   <finance-type code="110"></finance-type>
   <aid-type code="B01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-01"></transaction-date>
   <value currency="DKK" value-date="2020-05-01">10000000</value>
   <flow-type code="10"></flow-type>
   <finance-type code="110"></finance-type>
   <aid-type code="B01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <related-activity ref="XM-DAC-3-1-285898" type="1"></related-activity>
  <result type="2">
   <title>
    <narrative xml:lang="EN">Improved preparedness</narrative>
   </title>
   <reference code="268189" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">1. Advance access to safe and effective vaccines against emerging infectious diseases.
1.1. Investigational stockpiles established. 
1.2. Plans for trials and manufacture in place.</narrative>
    </title>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">1.1.1. Vaccines candidates developed</narrative>
   </title>
   <reference code="268192" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">1.1.1.
Through phase 2
Through phase 1
Through preclinical</narrative>
    </title>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="2">
   <title>
    <narrative xml:lang="EN">Improved response</narrative>
   </title>
   <reference code="268194" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">2. Accelerate the research, development and use of vaccines during outbreaks
2.1 Expected development and manufacture of vaccines for known and unknown pathogens
2.2. Facilitated field use and rapid response
2.3. Plans in place for testing and deployment during outbreaks</narrative>
    </title>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="2">
   <title>
    <narrative xml:lang="EN">Improved sustainability</narrative>
   </title>
   <reference code="268198" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">3. Sustainability
3.1. End-to-end market failures addressed
3.2. Costs reduced across the end to end spectrum of vaccine development
3.3. Successful products available to support outbreak response</narrative>
    </title>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">2.1.1. Pathogen specific vaccines on platforms progressing</narrative>
   </title>
   <reference code="268195" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">Through phase 1
Through phase preclinincal</narrative>
    </title>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">1.2.1. Vaccine development efforts enhanced</narrative>
   </title>
   <reference code="268193" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN"></narrative>
    </title>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">2.2.1. Development of technologies</narrative>
   </title>
   <reference code="268196" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN"></narrative>
    </title>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">2.3.1. End to end partners engaged</narrative>
   </title>
   <reference code="268197" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN"></narrative>
    </title>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">3.1.1. Predictability of financing improved</narrative>
   </title>
   <reference code="268199" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN"></narrative>
    </title>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">3.2.1. Efficiency improvements made</narrative>
   </title>
   <reference code="268200" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN"></narrative>
    </title>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">3.3.1. Contingency plans developed</narrative>
   </title>
   <reference code="268201" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN"></narrative>
    </title>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
